Related Experiment Video
Updated: Jun 8, 2026

07:10
A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues
Published on: February 19, 2019
The emergence of Staphylococcus aureus ST398
1Department of Epidemiology, Center for Emerging Infectious Diseases, University of Iowa, Iowa City, IA 52242, USA. tara-smith@uiowa.edu
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|October 8, 2010
Summary
Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA), particularly the ST398 strain, is emerging in humans and animals globally. This review examines its spread, infections, and control in agricultural settings.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) has evolved from a hospital-acquired pathogen to community-acquired infections.
- A novel group of MRSA strains linked to livestock, especially swine, has emerged globally.
- Livestock-associated MRSA (LA-MRSA) strains are now found in humans and animals across continents.
Purpose of the Study:
- To review the emergence and characteristics of livestock-associated MRSA (LA-MRSA).
- To describe the epidemiology, colonization, and clinical infections associated with the dominant ST398 strain.
- To discuss research gaps and strategies for controlling LA-MRSA spread.
Main Methods:
- Review of existing literature on MRSA epidemiology.
- Analysis of molecular typing data for LA-MRSA strains, focusing on ST398.
- Synthesis of information on human and animal infections and colonization.
Main Results:
- The ST398 strain is the predominant type of LA-MRSA identified globally.
- LA-MRSA has been detected in humans and animals in Europe, North America, and Asia.
- Colonization and clinical infections in humans are increasingly linked to this strain.
Conclusions:
- The emergence of LA-MRSA, particularly ST398, represents a significant epidemiological shift.
- Understanding transmission dynamics is crucial for controlling spread in agricultural and community settings.
- Further research is needed to address control strategies and potential public health implications.
Related Concept Videos
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
